Sign In

Login

Password

Forgot Password ? Sign Up

Bulbokapnina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bulbokapnina" in Polish language version.

refsWebsite
Global rank Polish rank
7doi.org
2nd place
6th place
7nih.gov
4th place
7th place
1web.archive.org
1st place
1st place
1sigmaaldrich.com
924th place
75th place
1aspetjournals.org
6,663rd place
7,639th place
1worldcat.org
5th place
2nd place

aspetjournals.org

jpet.aspetjournals.org

doi.org

  • A. Adsersen, A. Kjølbye, O. Dall, A.K. Jäger. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. Kort.. „Journal of Ethnopharmacology”. 113 (1), s. 179–182, 2007. DOI: 10.1016/j.jep.2007.05.006. PMID: 17574358. 
  • Y.H. Zhang, J.S. Shin, S.S. Lee, S.H. Kim i inni. Inhibition of tyrosine hydroxylase by bulbocapnine. „Planta Medica”. 63 (4), s. 362–363, 1997. DOI: 10.1055/s-2006-957702. PMID: 9270381. 
  • J.S. Shin, K.T. Kim, M.K. Lee. Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. „Neuroscience Letters”. 244 (3), s. 161–164, 1998. DOI: 10.1016/S0304-3940(98)00148-7. PMID: 9593514. 
  • J.D. Kohli, D. Glock, L.I. Goldberg. Bulbocapnine is not a selective DA1 receptor antagonist. „Journal of Pharmacy and Pharmacology”. 38 (5), s. 401-402, 1986. DOI: 10.1111/j.2042-7158.1986.tb04599.x. PMID: 2872323. 
  • Freund M., Josephy W.. Ueber die Alkaloïde, welche in der Wurzel von Corydalis cava (Schwgg.) enthalten sind. „Berichte der deutschen chemischen Gesellschaft”. 25 (2), s. 2411–2415, 1892. DOI: 10.1002/cber.18920250237. 
  • H. Jong, G. Schaltenbrand. Die Wirkung des Bulbocapnins auf Paralysis Agitans- und Andere Tremorkranke. „Klinische Wochenschrift”. 3 (45), s. 2045–2049, 1924. DOI: 10.1007/bf01737497. 
  • A. Loizzo, A.S. De Carolis, V.G. Longo. Studies on the central effects of bulbocapnine. „Psychopharmacologia”. 22 (3), s. 234–249, 1971. DOI: 10.1007/BF00401786. PMID: 5316197. 

nih.gov

ncbi.nlm.nih.gov

  • A. Adsersen, A. Kjølbye, O. Dall, A.K. Jäger. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. Kort.. „Journal of Ethnopharmacology”. 113 (1), s. 179–182, 2007. DOI: 10.1016/j.jep.2007.05.006. PMID: 17574358. 
  • Y.H. Zhang, J.S. Shin, S.S. Lee, S.H. Kim i inni. Inhibition of tyrosine hydroxylase by bulbocapnine. „Planta Medica”. 63 (4), s. 362–363, 1997. DOI: 10.1055/s-2006-957702. PMID: 9270381. 
  • J.S. Shin, K.T. Kim, M.K. Lee. Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. „Neuroscience Letters”. 244 (3), s. 161–164, 1998. DOI: 10.1016/S0304-3940(98)00148-7. PMID: 9593514. 
  • D.R. Burt, I. Creese, S.H. Snyder. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. „Molecular Pharmacology”. 12 (5), s. 800–812, 1976. PMID: 995128. 
  • J.D. Kohli, D. Glock, L.I. Goldberg. Bulbocapnine is not a selective DA1 receptor antagonist. „Journal of Pharmacy and Pharmacology”. 38 (5), s. 401-402, 1986. DOI: 10.1111/j.2042-7158.1986.tb04599.x. PMID: 2872323. 
  • S.B. Freedman, S. Patel, R. Marwood, F. Emms i inni. Expression and pharmacological characterization of the human D3 dopamine receptor. „Journal of Pharmacology and Experimental Therapeutics”. 268 (1), s. 417–426, 1994. PMID: 8301582. 
  • A. Loizzo, A.S. De Carolis, V.G. Longo. Studies on the central effects of bulbocapnine. „Psychopharmacologia”. 22 (3), s. 234–249, 1971. DOI: 10.1007/BF00401786. PMID: 5316197. 

sigmaaldrich.com

web.archive.org

worldcat.org

  • William S. Burroughs, Naked Lunch, James Grauerholz, Barry Miles, David L Ulin, wyd. 50th anniversary ed, New York: Grove Press, 2009, s. 73, ISBN 978-0-8021-1926-1, OCLC 318422237.